Press release
PARP Inhibitors Market: A Catalyst for Innovation in Breast, Ovarian, and Prostate Cancer Treatments
Request for Sample Pages: https://www.insightaceanalytic.com/report-details/global-parp-inhibitors-market-assessment/
According to the latest research by InsightAce Analytic, the global market for PARP inhibitors is expected to record a promising CAGR during the period of 2024-2031. PARP inhibitors are a collection of pharmacological inhibitors of the enzyme poly ADP ribose polymerase. They are developed for numerous indications, comprising the treatment of genetic cancers.
The growing prevalence of cancer is expected to boost the growth of market globally. Additionally, growing research and development activities for the development of PARP inhibitors, and presence of large number of drugs in pipeline are expected to boost the growth of market globally. The strategic collaboration among the key players operating in the market and, new product launches are also expected to boost the growth of market significantly.
Request for ToC/Proposal: https://www.insightaceanalytic.com/report-details/global-parp-inhibitors-market-assessment/
Global PARP Inhibitors market reports covers prominent players such as Johnson & Johnson, GlaxoSmithKline Plc., Clovis Oncology Inc., Pfizer, Inc., AbbVie Inc., Merck KGaA, Genentech, Inc., Artios Pharma, Sierra Oncology, Inc., KaryopharmTherapeutics Inc., Repare Therapeutics Inc., Ono Pharmaceutical Co., Ltd., Jiangsu Hengrui Medicine Co., Ltd., Bristol Myers Squibb, 2X Oncology, Cephalon, AstraZeneca Plc., Checkpoint Therapeutics, Eisai Co. Ltd, IMPACT Therapeutics, Jeil Pharmaceuticals, KuDOS Pharmaceuticals, Kyowa Hakko Kirin, Lead Therapeutics, Shanghai De Novo Pharmatech, SyntheX, and Tesaro among others.
Curious about this latest version of report? Obtain Report Details @ https://www.insightaceanalytic.com/report-details/global-parp-inhibitors-market-assessment/
Market Segments
Global PARP Inhibitors Market by Product Revenue (US$ Mn) Forecast 2024-2031
o Niraparib (Zejula)
o Olaparib (Lynparza)
o Rucaparib (Rubraca)
o Talazoparib (Talzenna)
o Veliparib
o Other Pipeline Drugs
Global PARP Inhibitors Market by Indication Revenue (US$ Mn) Forecast 2024-2031
o Ovarian Cancer
o Breast cancer
o Prostate and Pancreatic Cancer
Global PARP Inhibitors Market Based on Region Revenue (US$ Mn) Forecast 2024-2031
Europe PARP Inhibitors Market Revenue (US$ Mn) Forecast, by Country 2024-2031
o Germany
o Poland
o France
o Italy
o Spain
o UK
o Rest of Europe
North America PARP Inhibitors Market Revenue (US$ Mn) Forecast, by Country 2024-2031
o U.S.
o Canada
Asia Pacific PARP Inhibitors Market Revenue (US$ Mn) Forecast, by Country 2024-2031
Latin America PARP Inhibitors Market Revenue (US$ Mn) Forecast, by Country 2024-2031
Middle East & Africa PARP Inhibitors Market Revenue (US$ Mn) Forecast, by Country 2024-2031
Why should buy this report:
To receive a comprehensive analysis of the prospects for global PARP inhibitors market
To receive industry overview and future trends PARP inhibitors market
To analyze the PARP inhibitors market drivers and challenges
To get information on PARP inhibitors market size value/revenue (US$ Mn) forecast till 2028
Major Investments, Mergers & Acquisition in PARP Inhibitors industry
For More Information @ https://www.insightaceanalytic.com/report-details/global-parp-inhibitors-market-assessment/
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release PARP Inhibitors Market: A Catalyst for Innovation in Breast, Ovarian, and Prostate Cancer Treatments here
News-ID: 3517252 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd.
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis…
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"
The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Get Free Access…
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at…
Plasma Fractionation Market Robust Expansion is expected to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Plasma Fractionation Market- (By Product (Immune-Globulins(Intravenous Immune-Globulins, Subcutaneous Immune-Globulins, Other Immune-Globulins), Coagulation Factor Concentrates (Factor VIII, Factor IX, Von Willebrand Factor, Prothrombin Complex Concentrate, Fibrinogen Concentrates, Factor XIII, Others), Albumin, Protease Inhibitors, Other Plasma Products), By Application (Neurology, Immunology, Hematology, Critical Care, Pulmonology, Hemato-Oncology, Rheumatology, Others), By End-User (Hospitals & Clinics, Clinical Research Laboratories, Academic Institutes)),…
More Releases for PARP
PARP Inhibitor Biomarkers Market Size to Expand Lucratively by 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global PARP Inhibitor Biomarkers Market - (By Product (Kits, Assays), By Services (BRCA 1 & 2 Testing, HRD Testing, HRR Testing, Others), By Application (Breast Cancer, Ovarian Cancer, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global PARP Inhibitor Biomarkers Market is valued at US$ 879.8…
Parp Inhibitors Market Driven by Demand for Immersive Technologies Across Indust …
Global Parp Inhibitors Market Impact of AI and Automation
The PARP inhibitors market has seen remarkable growth in recent years, primarily driven by advances in cancer treatment and the increasing prevalence of cancer globally. These inhibitors, which block the enzyme poly (ADP-ribose) polymerase (PARP), are proving to be highly effective in targeting specific cancer cells, especially in cancers with DNA repair deficiencies like ovarian, breast, and prostate cancers. The approval of…
China Market Analysis of PARP Inhibitors: Growth Opportunities
Global PARP Inhibitors Market: Introduction
A PARP (poly ADP-ribose polymerase) inhibitor is a substance that blocks PARP enzyme in the cell. DNA damage occurs during cancer. Blocking of PARP helps the cancer cells in repairing their damaged part of DNA.
Read Report Overview - https://www.transparencymarketresearch.com/parp-inhibitors-market.html
Global PARP Inhibitors Market: Competition Landscape
Key players operating in the global PARP inhibitors market are AstraZeneca, Tesaro, AbbVie Inc., Medivation, and Clovis Oncology. The global market is…
PARP Inhibitors Market Trends and Segments
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
PARP Inhibitors Market Dynamics, Segments, Size and Demand, 2017 - 2027
Cancer is the leading cause of death worldwide with 8.2 million cancer related deaths in 2012 estimated by World Health Organization (WHO). PARP Inhibitors are the drugs, which inhibit the enzyme called poly ADP ribose polymerase (PARP). PARP inhibitors developed for treating several diseases, the most important one is cancer. As several types of cancers rely on PARP than regular cells, which makes it attractive target for treating cancers. These…
Global PARP Inhibitor Market: Size, Trends And Forecasts (2016-2020)
Scope of the Report
The report titled Global PARP Inhibitor Market: Size, Trends and Forecasts (2016-2020) provides an in-depth analysis of the global PARP inhibitor market with detailed analysis of market size on the basis of value along with the comprehensive examination of each of the segments of the market, namely, Lynparza, Niraparib, Rucaparib, Talazoparib and Veliparib.
The report analyses the global Lynparza market in detail along with the regional analysis as…
